BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Biofuel, Cisplatin, rs2476601, FXYD4, T cell differentiation, Influenza, Hippocampus)
Bookmark Forward

QuickView for CRLF2 (gene)


Body Atlas

Most Correlated Tissues

  1. Skeletal muscle psoas
  2. Superior cervical ganglion
  3. Extraocular muscle
  4. Cerebellum peduncles
  5. Adrenal gland
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disease due to Trypanosomatidae
  2. Candidiasis
  3. Salmonella infection
  4. Aspergillosis
  5. Nephrotic syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. IL33 protein, human
  2. Nickel
  3. Mebendazole
  4. S-(dimethylarsino)-glutathione
  5. Adenosine Triphosphate
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. BP1
  2. INTS11
  3. EFEMP2
  4. MMP19
  5. MIR181A1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
  2. Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in CRLF2-Rearranged Ph-like ALL.
  3. Effects of different aberrations in the CRLF2 gene on the biological characteristics and drug sensit…
  4. Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
  5. Combined analysis of IKZF1 deletions and CRLF2 expression on prognostic impact in pediatric B-cell p…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL
  2. INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloprol…
  3. Effect of Mepolizumab on Severe Eosinophilic Asthma
  4. A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
  5. Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy i…
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.